Lawsuits Against AndroGel Continue to Be Filed
Every prescription medication has its risks, but it is the responsibility of the drug company to disclose the potential side effects and risks of taking the medication. When drug companies in Philadelphia try to minimize the risks or use unethical tactics in order to get people to use their medication, serious consequences can occur.
A group of men are suing AbbVie, Inc and Abbot Laboratories, the makers and marketers of AndroGel, a testosterone gel, for these very reasons. Five men filed lawsuits on February 4, 2014, and another one filed on March 12, 2014. The five men say that they were not aware of the increased risk of heart problems while on AndroGel and that the drug company did not sufficiently warn them of the risks. They claim that after taking AndroGel, they suffered heart attacks or strokes.
In the latest lawsuit, the man also alleges that he was not properly warned of the risks and that he suffered three heart attacks as a result of being on the dangerous drug. He says that he will now be required to take medication, alter his diet and have his heart checked regularly because he is now at a higher risk of stroke, heart disease and even death.
The plaintiffs in these lawsuits say that the manufacturers of AndroGel used unethical marketing strategies to promote their drug and encouraged doctors to prescribe it in order to help with increased vitality and libido in older men. This goes against what the FDA approved testosterone therapy for, which is a condition known as hypogonadism.
Source: Injury Lawyer News, “New AndroGel Lawsuit Filed in Chicago,” Katarina Siegfeld, Mar. 21, 2014